On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Kevin B. Kim

ResearcherPublications, citations & collaboration network

Kevin B. Kim is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Kevin B. Kim have?

ScholarIQindexed works

Kevin B. Kim has 246 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Kevin B. Kim have?

ScholarIQcitation count

Kevin B. Kim has 21,837 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Kevin B. Kim?

ScholarIQh-index

Kevin B. Kim has an h-index of 53 in OpenAlex.

What is the i10-index of Kevin B. Kim?

ScholarIQi10-index

Kevin B. Kim has an i10-index of 111 in OpenAlex.

What is the ORCID of Kevin B. Kim?

ScholarIQorcid

The ORCID for Kevin B. Kim is on the source record.

What is the OpenAlex record for Kevin B. Kim?

ScholarIQopenalex

The OpenAlex for Kevin B. Kim is on the source record.

What are the most-cited papers on Kevin B. Kim?

ScholarIQmost cited works
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante, Michael S. Gordon, Nicholas J. Vogelzang, Douglas J. DeMarini, Peng Sun, Christopher Moy, Stephen A. Szabo, Lori Roadcap, Vijay Peddareddigari, Peter F. Lebowitz, Ngocdiep T. Le, Howard A. Burris, Wells A. Messersmith, Peter J. O’Dwyer, Kevin B. Kim, Keith T. Flaherty, Johanna C. Bendell, René González, Razelle Kurzrock, Leslie A. Fecher
The Lancet Oncology. 2012545 CitationsOPEN ACCESS
Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic <i>BRAF</i> -Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor
Kevin B. Kim, Richard Kefford, Anna C. Pavlick, Jeffrey R. Infante, Antoni Ribas, Jeffrey A. Sosman, Leslie A. Fecher, Michael Millward, Grant A. McArthur, Patrick Hwu, René González, Patrick A. Ott, Georgina V. Long, Olivia Gardner, Danièle Ouellet, Yanmei Xu, Douglas J. DeMarini, Ngocdiep T. Le, Kiran Patel, Karl D. Lewis
Journal of Clinical Oncology. 2012478 CitationsOPEN ACCESS
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski, Jean‐François Baurain, Max Schlaak, Marcus O. Butler, Ryan J. Sullivan, Reinhard Dummer, John M. Kirkwood, Marlana Orloff, Joseph J. Sacco, Sebastian Ochsenreither, Anthony M. Joshua, Lauris Gastaud, Brendan D. Curti, Josep M. Piulats, April K.S. Salama, Alexander N. Shoushtari, Lev Demidov, Mohammed Milhem, Bartosz Chmielowski, Kevin B. Kim, Richard D. Carvajal, Omid Hamid, Laura Collins, Koustubh Ranade, Chris Holland, Constance R. Pfeiffer, Paul Nathan
New England Journal of Medicine. 2023275 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account